This study builds on previous research which
shows that behavioral support programs can help increase
quit success rates.
The CQ PLAN was developed by HealthMedia, Inc.S.tobacalert.
One study
, "Validating a Dipstick Method for Detecting Recent
Smoking," Cancer Epidemiology, Biomarkers + Prevention
(2002;
11:1123-1125) examined the smoking status of patients at a cancer
clinic and found that
the results obtained using Nymox's tobacco
product exposure test had an "excellent agreement" with
state-of-the-art sophisticated laboratory measurements but at a
substantially lower cost (over
90% less).9 million people a year and that this death toll
will rise to 10 million a year by 2020
.
smokers cessation
The Internet
offers incredible potential to reach a large number of smokers with smoking
cessation
support and information that has been proven effective."
Medicinal nicotine can double a quitter
's chance of success versus
quitting with cold turkey. There
can be no assurance that such statements
will prove to be accurate and
the actual results and future events could differ materially from
management
's current expectations.quit smokers
"
The U.smokers nic
The
study, a large-scale controlled trial of an automated Web
-based smoking
cessation intervention, evaluated the impact of the Committed Quitters Stop
Smoking
Plan (CQ PLAN) among 3,971 participants. Years of smoking make the smoker's brain dependent on nicotine
--
the brain craves nicotine and these cravings can be difficult to resist. NicAlert(TM) has received
U.anon quit
Smoking addiction has two basic causes: nicotine
and habit.
TobacAlert(TM) and NicAlert(TM
) are easy to use and provide
results within minutes.S.
As featured in a recent Wall Street Journal
story (April 26, 2005,
"Case Grows to Cover Quitting"), taking action against smoking and
second
-hand smoke exposure is becoming a priority for both public
health authorities and private employers
.motley anon
The plan provides support and information to smokers throughout
their quit attempt, even if they
live in areas without smoking cessation
services. At both 6- and 12-week follow up,
smokers enrolled
in the CQ PLAN had significantly higher rates of cessation. Its more than 30 well-
known brands
include the leading smoking cessation products, Nicorette(R),
NicoDerm(R) and Commit(R), as well
as many medicine cabinet staples,
Abreva(R), Aquafresh(R), Sensodyne(R) and Tums(R).
About
GlaxoSmithKline
GlaxoSmithKline is one of the world's leading research-based
pharmaceutical
and consumer healthcare companies. are in
attendance to participate in over 240 workshop and educational
sessions on second-hand smoke exposure, smoking cessation programs,
and other tobacco control
related issues.S.
NicAlert(TM) has been successfully used in public health
initiatives (such as
, for example, smoking cessation programs and
quit-smoking contests) in the U.S. Many sites provide
up to the minute news on issues related to health.
quit smokers
Study participants were randomly assigned
to one of two treatment groups
after purchasing the NicoDerm(R) CQ(R) patch and enrolling in the
program: one
group receiving the personalized CQ PLAN, the other group receiving non-
tailored
Web-based cessation materials. Testing can be done almost anywhere, including
at home, the workplace
or school and no instruments are required. Several dozen major
corporations currently offer coverage
for smoking cessation programs
to millions of employees and their dependents as part of a
comprehensive
cancer screening and prevention program.just4u quitters
"Medicinal nicotine addresses
the smoker's physical need
for nicotine, while tailored behavioral support
programs can help with the mental components of smoking
., Switzerland and Canada.encouragement anon
Worldwide, the WHO estimates that tobacco use and exposure
currently kills
4.com, email:
info@nymox.nic bulletin
More information is available at
www. A large European
clinical
trial found significant smoking reduction over the four-month
trial period when nicotine replacement
therapy (NRT) was combined with
individual cotinine levels as measured by NicAlert(TM).S. Surgeon
General, the Centers for Disease Control and
Prevention (CDC), the World Health Organization (WHO
) and many other
public health organizations have targeted tobacco use as the single
most preventable
cause of premature death today.anon just4u
quitsmoking trying
GSK Consumer Healthcare offers the widest range of proven products
including two strengths of the Commit(R) lozenge; two starting strengths of
clear and opaque NicoDerm
CQ patches; and two strengths, four flavors and two
formulas of Nicorette(R) gum. GSK Consumer Healthcare
's stop-smoking products
have helped millions of smokers stop smoking by providing low, safe doses
of
nicotine to ease withdrawal from cigarettes.
"This conference has provided us with a wonderful
opportunity to
introduce our tobacco exposure products, TobacAlert(TM) and
NicAlert(TM), to a
wide range of opinion leaders and activists in this
important sector," said Brian Doyle, Global Sales
Manager for Nymox
Pharmaceutical Corporation (NASDAQ:NYMX). The CDC estimates
that smoking causes
over 440,000 premature deaths annually in the
United States and creates an economic loss of over
$150 billion a
year.quitting quitsmoking
GSK Consumer Healthcare's CQ PLAN is the only such program proven to increase
success rates for quitters.com. as well
as online at www.Sites in this category serve the support
needs of people who currently smoke and wish to quit.
fool encouragement
D. GSK Consumer Healthcare
continues to develop
innovative products to help all smokers find their best
support system and achieve their goal of
being cigarette free. The products measure the level of cotinine, a metabolite of
nicotine, in urine
.cvs. The treaty requires the adoption and
implementation of measures to reduce exposure to second
-hand smoke, to
diagnose tobacco dependence and to promote tobacco use cessation.cessation smokers
CQ PLAN materials
can be personalized according to the smokers'
demographics, smoking history, motives for quitting
and anticipated
challenges. Nicotine dependency is stronger and lasts longer than many people
realize
.
In February 2005, the WHO Framework Convention on Tobacco Control
came into effect in 57 countries
.nymox.
The sites provide information and resources.
gum cessation
Quitting smoking
doesn't have to be the same
old failed battle using cold turkey.
Medicinal nicotine helps curb cravings for nicotine, allowing
the quitter to
focus on changing smoking habits.cessation trying
More than 2,800 doctors, nurses, researchers,
lawmakers
and tobacco control activists from across the U. Cotinine is widely accepted and commonly used in
medical
research and public health studies to determine the extent of
tobacco product use or exposure.nicotine encouragement
Studies
have shown that NicAlert(TM) can help smokers quit.buddies quitting
Department of Health and Human Services (HHS
) report entitled
"Prevention Makes Common 'Cents'" found that covering treatments to
help employees
quit smoking offers substantial savings for employers
in the costs of treating smoking-related illness
.com
This press release contains certain "forward-looking statements"
as defined in the United
States Private Securities Litigation Reform
Act of 1995 that involve a number of risks and uncertainties
. Such factors are detailed from time
to time in Nymox's filings with the United States Securities
and
Exchange Commission and other regulatory authorities.
All sites listed are interactive - you
will find message boards
motley anon
About GlaxoSmithKline Consumer Healthcare
GlaxoSmithKline
Consumer Healthcare is one of the world's largest over-
the-counter consumer healthcare products
companies.
More information about Nymox is available at www.anon nic
New Study Confirms Internet Can Provide
Real Support For Smokers Who Want to Quit
PITTSBURGH, A new study published in the current
issue
of Addiction indicates that smokers who use medicinal nicotine together
with GlaxoSmithKline (GSK
) Consumer Healthcare's individualized Web-based
support program greatly increase their chances of
successfully quitting. for GSK Consumer Healthcare
and is available free to all smokers who purchase
their medicinal nicotine
products in the United States, United Kingdom, Republic of Ireland, Italy
, and
Germany. Beyond the proven medicine in
these products, smokers can receive specific tips
for success and advice about
staying smoke-free through the GSK Consumer Healthcare Web site
http:
//www.quit. GlaxoSmithKline is
committed to improving the quality of human life by enabling people
to do
more, feel better and live longer.
Business Editors/Health Editors/Medical Editors
2005
National Conference on Tobacco or Health
CHICAGO----
Nymox (NASDAQ:NYMX) TobacAlert(TM
) Product Detects Second-Hand Smoke
Exposure; Available Nationwide at Over 5400 CVS/pharmacy(R) Stores
Second-hand smoke exposure and smoking cessation head
the agenda at the 2005 National Conference
on Tobacco or Health in
Chicago this week. "The level of interest in
our products has been tremendous
.com. FDA clearance for
medical use for determining an individual's exposure to tobacco
products
.msn quitters
Medicare recently announced
coverage for smoking cessation counseling services for millions of its
beneficiaries who smoke and have been diagnosed with a smoking related
disease or are taking certain
drugs affected by tobacco use.bulletin patch
, author of the study.Second-Hand Smoke Exposure a Key Topic at National
Conference on Tobacco or Health
"
Nymox's revolutionary products, TobacAlert(TM) and NicAlert
(TM),
provide a cost-effective, on-site means to test for tobacco exposure
and use.
TobacAlert
(TM) measures second-hand smoke exposure levels and is
available at over 5,400 CVS/pharmacy(R) stores
across the U.
trying smokers
com. A U.
Independent studies have found the Nymox technology to be an
accurate
, rapid and cost-effective means of confirming smoking status. Another peer-reviewed study,
"The Accuracy
of Self-Reported Smoking Status Assessed by Cotinine
Test Strips," Nicotine + Tobacco Research (2002;
4:305-9) found
Nymox's product to be "an inexpensive and rapid method to routinely
bio-chemically
confirm smoking status at a clinical visit." The
authors described the Nymox product as a "simple
, inexpensive and
rapid measure to immediately confirm smoking status in field
settings.trying cessation
Smokers
who used the program
were 34% more likely to have quit smoking after 12 weeks, compared to those
who used a non-tailored plan.
"There are two aspects of tobacco addiction, the physical and
the mental,"
said Saul Shiffman, Ph.S.
The ability of Nymox's tobacco exposure testing technology
to
measure second-hand smoke exposure has been successfully put to the
test by reporters, as reported
recently in the New York Daily News
"Guinea Pig" column (April 27, 2005) and earlier in the London
Sunday
Telegraph (January 25, 2004) and Melbourne, Australia's The Sunday
Herald Sun (June 26
, 2004).buddies trying
A community sponsored library.
-> Show WiseVault's Web Sites Listing For This Topic
Loading...
(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)